Neuropathology: About Us

The Neuropathology Division is an integral part of the University of Washington's Pathology Department and Neurosciences program. We provide diagnostic support to neurosurgery, neurology, neuro-oncology and ophthalmology clinical services throughout the affiliated University hospitals, as well as maintain an excellent training program.

The Neuropathology training program is maintained through daily discussions and specimen review, weekly brain cutting sessions, Neuropathology Conferences, and the Research in Progress Seminar.

Our clinical interests span virtually all of diagnostic neuropathology, including developmental, ocular, muscle and peripheral nerve, degenerative, and surgical neuropathology.

Several members of the Neuropathology Division have active and well-funded research laboratories. Our research interests include degenerative diseases of the central nervous system, particularly Alzheimer's Disease and Parkinson's Disease, stroke, neoplasia, epilepsy and developmental neurobiology.


Patrick (P.J.) Cimino, MD, PhD, UW Medicine Pathology, Division of Neuropathology, Acting Assistant Professor.  Shortly before joining the UW faculty in 2015, Dr. Cimino was awarded the F. Stephen Vogel Award at the 2015 annual meeting for the United States and Canadian Academy of Pathology (USCAP). 

Luis Gonzalez-Cuyar, MD, UW Medicine Pathology, Division of Neuropathology, Acting Assistant Professor, research referenced in The Economist article "Manganese Poisoning Subtle Effects: Exploring the Link Between Manganese and Parkinson's Disease". 

C. Dirk Keene, MD, PhD, UW Medicine Pathology, Division of Neuropathology, Associate Professor and Service Leader of Neuropathology, as one of the primary investigators, leads Traumatic Brain Injury Study funded by The Paul G. Allen Family Foundation. 

Jing Zhang, MD, PhD, Professor and Director of Neuropathology, UW Medicine Pathology, mainly engaged in translational investigation of neurodegenerative disorders over the last few years—especially Alzheimer’s disease (AD) and Parkinson’s disease (PD)—with a special emphasis on biomarkers. His recent research shows counterintuitive findings offering new insights into Parkinson Disease pathology.